Kevin advises clients on a range of commercialization strategies including supply chain and new drug launches.
He has a deep expertise in commercialization, operations, strategy and execution.
Prior to joining Avalere, Kevin led RxCrossroads by McKesson’s third-party logistics (3PL) business where he was responsible for breaking into a challenging market with long-established competition, developing a strategy to target small and midsized drug manufacturers to help commercialize their drug products, and creating value-based relationships to provide ongoing business development opportunities. Kevin had overall profit and loss responsibility and led the business from a startup within McKesson to an industry-recognized market leader with over 100 biopharma customers.
Before RxCrossroads, Kevin was responsible for the vaccine business within the McKesson Specialty Health division. Kevin designed the business growth strategy, developed marketing, education and sales incentive plans, and built and managed a cross functional leadership team of operations, account management, finance, human resources, and customer care members to enhance collaboration and align common objectives. Kevin also oversaw McKesson’s Centers for Disease Control and Prevention centralized distribution contract supporting the Vaccines for Children Program.
Prior to that, Kevin delivered SAP and special projects in support of new customer launches, new drug rollouts and distribution services. He sat on McKesson’s executive leadership team with overall responsibility for IT functions in support of the H1N1 pandemic response, which included warehousing and distributing over 125 million doses of H1N1 flu vaccine.
Kevin has a BS in economics from the University of Delaware